This content is machine translated Hepatocellular carcinoma When is liver transplantation a reasonable treatment option? When patients with hepatocellular carcinoma (HCC) meet certain criteria for tumor size, tumor number, and metastasis, liver transplantation may be a reasonable treatment option. The allocation of available organs is…
View Post 4 min This content is machine translated Onco-Training St. Gallen News on metastatic colorectal cancer Metastatic colorectal cancer was the focus of an afternoon symposium in St. Gallen. Significant progress has been made in the field of colorectal cancer therapy in recent years, but this…
View Post 7 min This content is machine translated Patient Competency “There is an increased need for micronutrients under chemotherapy”. In an interview with InFo ONCOLOGY & HEMATOLOGY, Prof. Gerd Nagel, MD, internal oncologist and founder of the Patient Competence Foundation Switzerland, spoke about the meaning of the word “patient…
View Post 2 min This content is machine translated Metastatic colorectal cancer Does vitamin D put the brakes on tumors? Prospective analysis of a phase III trial of metastatic colorectal cancer shows that higher vitamin D levels provide better outcomes. Patients not only lived significantly longer, but also later became…
View Post 2 min This content is machine translated Oral mucositis during radiotherapy Does flushing with tricyclic antidepressant help? Oral mucositis may occur as a side effect of radiotherapy for head and neck tumors. This is frequent, sometimes extremely painful and clearly limits the therapeutic options. Pain-relieving medications are…
View Post 7 min This content is machine translated Gynecology How to proceed with dysplasia? Women with known immunosuppression should receive annual cervical screening. When cervical screening is performed, the perianal, vulvar, and vaginal areas should also be inspected. The use of a screening procedure…
View Post 4 min This content is machine translated News from dermatooncology Melanoma with or without BRAF mutation – new therapies in the pipeline Data from two phase III trials (both from the research group led by Caroline Robert, MD, Institut Gustave Roussy in Villejuif, Paris) published earlier this year highlight the rapid development…
View Post 2 min This content is machine translated Obesity and adenomas Visceral fat as a mediator Previously, when epidemiological studies examined the association between obesity and colorectal neoplasia, body mass index (BMI) and abdominal circumference were usually used. These two parameters do not distinguish between visceral…
View Post 7 min This content is machine translated Red blood cell concentrates and erythropoiesis-stimulating agents Blood transfusions in oncology – when and for whom? In tumor patients, treatable causes of anemia should also be deliberately sought before transfusion. No transfusion due to falling below a “transfusion trigger”: The indication for a transfusion should always…
View Post 8 min This content is machine translated Radiotherapy for bone metastases Primary goals are pain reduction and functional preservation When treating bone metastases, interdisciplinary discussion is necessary to ensure an optimal multimodal therapy regimen and thus the best possible outcome for the patient. Radiotherapy is considered the treatment of…
View Post 7 min This content is machine translated Radical surgery as a treatment option Prophylactic mastectomy – for which patients is it an option? Prophylactic mastectomy reduces the risk of breast cancer by more than 95% in a healthy BRCA mutation carrier. However, intensified screening is a good alternative to surgery. For a diseased…
